Biotest AG, established in 1946 and headquartered in Dreieich, Germany, develops, manufactures, and distributes biological medicines including clotting factors, immunoglobulins, albumin, and monoclonal antibodies. The company operates subsidiaries across Europe and Brazil and owns plasma collection centers in Germany, Hungary, and the Czech Republic. It specializes in clinical immunology, hematology, and intensive care medicine. Biotest AG has extensive experience in international trade, having conducted over 640 trade transactions with countries such as the Russian Federation, India, Kazakhstan, Pakistan, Colombia, Bangladesh, Uzbekistan, Ecuador, Peru, and Ghana.